Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,397,760 papers from all fields of science
Search
Sign In
Create Free Account
Kurtzke multiple sclerosis rating scale
Known as:
EDSS
, Expanded Disability Status Scale
, Kurtzke Expanded Disability Status Scale
A system for quantifying disability in multiple sclerosis (MS). Based on a standard neurological examination, the Expanded Disability Status Scale…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Kurtzke Expanded Disability Status Scale Questionnaire
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score
P. Invernizzi
,
L. Bertolasi
,
M. Bianchi
,
M. Turatti
,
A. Gajofatto
,
M. Benedetti
Journal of Neurology
2011
Corpus ID: 24672664
Evoked potentials (EPs) have long been used as diagnostic tools in multiple sclerosis (MS), although their importance decreased…
Expand
Highly Cited
2010
Highly Cited
2010
Cognitive impairment after three decades of multiple sclerosis
C. Smestad
,
Leiv Sandvik
,
N. I. Landrø
,
E. Celius
European Journal of Neurology
2010
Corpus ID: 205581562
Background: Population‐based studies of cognitive impairment in patients with multiple sclerosis (MS) with long disease duration…
Expand
Highly Cited
2010
Highly Cited
2010
Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group…
M. Ravnborg
,
P. Sørensen
,
+8 authors
Bjørn Sperling
Lancet Neurology
2010
Corpus ID: 23777817
Highly Cited
2010
Highly Cited
2010
Swedish natalizumab (Tysabri) multiple sclerosis surveillance study
F. Piehl
,
C. Holmén
,
J. Hillert
,
T. Olsson
Neurological Sciences
2010
Corpus ID: 23710088
A post-marketing surveillance program was implemented to monitor the safety and open label efficacy of natalizumab since its…
Expand
Highly Cited
2008
Highly Cited
2008
Contribution of relapses to disability in multiple sclerosis
C. Hirst
,
G. Ingram
,
O. Pearson
,
T. Pickersgill
,
N. Scolding
,
N. Robertson
Journal of Neurology
2008
Corpus ID: 189867217
The impact of relapses on long-term disability in multiple sclerosis remains unclear; however some evidence suggests that…
Expand
Highly Cited
2005
Highly Cited
2005
Is inflammation important in early PPMS? a longitudinal MRI study
G. Ingle
,
J. Sastre-Garriga
,
D. Miller
,
A. Thompson
Journal of Neurology Neurosurgery & Psychiatry
2005
Corpus ID: 5681375
Background: Magnetic resonance imaging (MRI) studies in primary progressive multiple sclerosis (PPMS) have shown a reduced…
Expand
Highly Cited
2004
Highly Cited
2004
Neutralizing antibodies reduce the efficacy of βIFN during treatment of multiple sclerosis
S. Malucchi
,
A. Sala
,
+4 authors
A. Bertolotto
Neurology
2004
Corpus ID: 22755776
Objective: To analyze the impact of neutralizing antibodies (NAbs) on the clinical efficacy of IFNβ. Methods: This was an open…
Expand
Highly Cited
2000
Highly Cited
2000
T cell vaccination in secondary progressive multiple sclerosis
J. Correale
,
B. Lund
,
M. Mcmillan
,
D. Ko
,
K. Mccarthy
,
L. Weiner
Journal of Neuroimmunology
2000
Corpus ID: 45340439
Highly Cited
1999
Highly Cited
1999
The role of spouse responses to disability and family environment in multiple sclerosis.
L. Schwartz
,
G. Kraft
American Journal of Physical Medicine…
1999
Corpus ID: 44420695
Research in the area of family issues and multiple sclerosis has mainly focused on the impact of multiple sclerosis on the spouse…
Expand
Highly Cited
1994
Highly Cited
1994
Longitudinal MRI in multiple sclerosis
S. Khoury
,
C. Guttmann
,
+7 authors
H. Weiner
Neurology
1994
Corpus ID: 12878443
We followed 18 multiple sclerosis patients clinically and with repeated brain MRIs with and without gadolinium for over 1 year…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required